SCHEMBL4624059

SCHEMBL4624059

COc1cccc(OC)c1-c1ccc2cc(CC(C)(NC(=O)c3c(Cl)cccc3Cl)C(=O)O)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 11/20 0.50
ITGB1 P05556 9/20 0.50
ITGB7 P26010 8/20 0.41
FABP4 P15090 2/20 0.38
FABP3 P05413 1/20 0.36
FABP5 Q01469 1/20 0.36
HSD17B1 P14061 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
ALOX12 P18054 1/20 0.35
MAPK1 P28482 1/20 0.35
THPO P40225 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4625291 0.86 ITGB1 (0.39) ITGA4ITGB1ITGB7HSD17B1KDM4E
SCHEMBL4624872 0.85 ITGB1 (0.51) ITGA4ITGB1ITGB7FABP4LMNA
SCHEMBL4625005 0.80 ITGB1 (0.40) ITGA4ITGB1ITGB7ALDH1A1POLB
SCHEMBL3314549 0.78 ITGB1 (0.61) ITGA4ITGB1ITGB7
SCHEMBL3319930 0.77 ITGB1 (0.61) ITGA4ITGB1ITGB7KDM4EALDH1A1
SCHEMBL3312750 0.76 ITGA4 (0.58) ITGA4ITGB1ITGB7
SCHEMBL6142440 0.76 ITGB1 (0.42) ITGA4ITGB1ITGB7KDM4EALDH1A1
SCHEMBL4627490 0.73 ITGA4 (0.49) ITGA4ITGB1ITGB7LMNAMAPT
SCHEMBL1028112 0.72 ITGB1 (0.55) ITGA4ITGB1ITGB7KDM4EALDH1A1
SCHEMBL13398463 0.71 ITGB1 (0.50) ITGA4ITGB1ITGB7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-B1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF VLA-4 DEPENDENT DISEASES UCB PHARMA SA (BE) 2008-01-23 EP disclosed
EP-1870402-A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors UCB Pharma, S.A. (BE) 2007-12-26 EP disclosed